Differential response to bacteria, and tollip expression, in the human respiratory tract

BMJ Open Respiratory Research

Volumn 1, Issue 1, 2014, Pages

  Moncayo Nieto, Olga Lucia ^a,b   Wilkinson, Thomas S ^c   Brittan, Mairi ^a   McHugh, Brian J ^a   Jones, Richard O ^a   Morris, Andrew Conway ^a,d   Walker, William S ^e   Davidson, Donald J ^a   Simpson, A John ^a,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MESSENGER RNA; PEPTIDOGLYCAN; PROTEIN; TOLL INTERACTING PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL STIMULATION; CLINICAL ARTICLE; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CPG ISLAND; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; LUNG ALVEOLUS EPITHELIUM CELL; MALE; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STAPHYLOCOCCUS AUREUS;

EID: 85006675774     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2014-000046     Document Type: Article

References (29)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160–6.
2. Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;65:867–903.
3. Burns K, Clatworthy J, Martin L, et al. TOLLIP, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000;2:346–51.
4. Zhang Z, Ghosh S. Negative regulation of Toll-like receptor-mediated signaling by TOLLIP. J Biol Chem 2002;277:7059–65.
5. Melmed G, Thomas LS, Lee N, et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003;170:1406–15.
6. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor ligands in intestinal epithelial cells. Gastroenterology 2004;126:1054–70.
7. McDougall CM, Blaylock MG, Douglas JG, et al. Nasal epithelial cells are surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 2008;39:560–8.
8. Witherden IR, Tetley TD. Isolation and culture of human alveolar type II pneumocytes. Methods Mol Med 2001;56:137–46.
9. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncitial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-8. Am J Respir Cell Mol Biol 1993;8:20–7.
10. O’Brien GJ, Riddell G, Elborn JS, et al. Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir Res 2006;7:115.
11. Kenney JS, Baker C, Welch MR, et al. Synthesis of interleukin-1 alpha, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 1994;93:1060–7.
12. Haessler SD, Brown RB. Pneumonia caused by Staphylococcus aureus. Curr Respir Med Rev 2009;5:62–7.
13. Armstrong L, Medford AR, Uppington KM, et al. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004;31:241–5.
14. Thorley AJ, Grandolfo D, Lim E, et al. Innate immune response to bacterial ligands in the peripheral human lung—role of alveolar epithelial TLR expression and signalling. PLoS ONE 2011;6:e21827.
15. Zhang Z, Louboutin JP, Weiner DJ, et al. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun 2005;73:7151–60.
16. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human Toll-like receptors and related genes. Biol Pharm Bull 2005;28:886–92.
17. Ritter M, Mennerich D, Weith A, et al. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory responses. J Inflamm (Lond) 2005;2:16.
18. Chang LC, Hua CC, Chu CM, et al. Differential mRNA expression of Toll-like receptors and their adaptors in pleural effusions. Respirology 2009;14:1194–9.
19. Bulut Y, Faure E, Thomas L, et al. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001;167:987–94.
20. Piao W, Song C, Chen H, et al. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-β-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009;86:863–75.
21. Shibolet O, Podolsky DK. TLRs in the gut. IV. Negative regulators of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol 2007;292: G1469–73.
22. Song Z, Yin J, Yao C, et al. Variants in the Toll-interacting protein gene are associated with susceptibility to sepsis in the Chinese Han population. Crit Care 2011;15:R12.
23. Shah JA, Vary JC, Chau TT, et al. Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol 2012;189:1737–46.
24. Schimming TT, Parwez Q, Petrasch-Parwez E, et al. Association of Toll-interacting protein gene polymorphisms with atopic dermatitis. BMC Dermatol 2007;7:3.
25. Kalliomäki M, Satokari R, Lähteenoja H, et al. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 2012;54:727–32.
26. Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE 2011;6:e17776.
27. Witherden IR, Vanden Bon EJ, Goldstraw P, et al. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 2004;30:500–9.
28. Lee WK, Ramanathan M Jr, Spannhake EW, et al. The cigarette smoke component acrolein inhibits expression of the innate immune components IL-8 and human beta-defensin 2 by sinonasal epithelial cells. Am J Rhinol 2007;21:658–63.
29. Wong MH, Johnson MD. Differential response of primary alveolar type I and type II cells to LPS stimulation. PLoS ONE 2013;8: e55545.